Loading...
A purified reconstituted bilayer matrix shows improved outcomes in treatment of non-healing diabetic foot ulcers when compared to the standard of care: Final results and analysis of a prospective, randomized, controlled, multi-centre clinical trial
Armstrong, David G. Orgill, Dennis P. Galiano, Robert D. Glat, Paul M. Kaufman, Jarrod P. Carter, Marissa J. DiDomenico, Lawrence A. Zelen, Charles M.
Armstrong, David G.
Orgill, Dennis P.
Galiano, Robert D.
Glat, Paul M.
Kaufman, Jarrod P.
Carter, Marissa J.
DiDomenico, Lawrence A.
Zelen, Charles M.
Citations
Altmetric:
Genre
Journal article
Date
2024-04-12
Advisor
Committee member
Group
Department
Surgery
Permanent link to this record
Collections
Files
Research Projects
Organizational Units
Journal Issue
DOI
https://doi.org/10.1111/iwj.14882
Abstract
As the incidence of diabetic foot ulcers (DFU) increases, better treatments that improve healing should reduce complications of these ulcers including infections and amputations. We conducted a randomized controlled trial comparing outcomes between a novel purified reconstituted bilayer membrane (PRBM) to the standard of care (SOC) in the treatment of non-healing DFUs. This study included 105 patients who were randomized to either of two treatment groups (n = 54 PRBM; n = 51 SOC) in the intent to treat (ITT) group and 80 who completed the study per protocol (PP) (n = 47 PRBM; n = 33 SOC). The primary endpoint was the percentage of wounds closed after 12 weeks. Secondary outcomes included percent area reduction, time to healing, quality of life, and cost to closure. The DFUs that had been treated with PRBM healed at a higher rate than those treated with SOC (ITT: 83% vs. 45%, p = 0.00004, PP: 92% vs. 67%, p = 0.005). Wounds treated with PRBM also healed significantly faster than those treated with SOC with a mean of 42 versus 62 days for SOC (p = 0.00074) and achieved a mean wound area reduction within 12 weeks of 94% versus 51% for SOC (p = 0.0023). There were no adverse events or serious adverse events that were related to either the PRBM or the SOC. In comparison to the SOC, DFUs healed faster when treated with PRBM. Thus, the use of this PRBM is an effective option for the treatment of chronic DFUs.
Description
Citation
Armstrong DG, Orgill DP, Galiano RD, et al. A purified reconstituted bilayer matrix shows improved outcomes in treatment of non-healing diabetic foot ulcers when compared to the standard of care: Final results and analysis of a prospective, randomized, controlled, multi-centre clinical trial. Int Wound J. 2024; 21(4):e14882. doi:10.1111/iwj.14882
Citation to related work
Wiley
Has part
International Wound Journal, Vol. 21, Iss. 4
ADA compliance
Embedded videos
License
Attribution-NonCommercial-NoDerivs CC BY-NC-ND